Emactuzumab (CSF1R/CD115) - Research Grade Biosimilar
Product Specifications
Background
Emactuzumab is under investigation in clinical trial NCT01494688 (A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors) .
Immunogen
Humanized / CSF1R/CD115 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-666
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
RG7155, RO5509554
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
